BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3534568)

  • 1. Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study.
    Simberkoff MS; Cross AP; Al-Ibrahim M; Baltch AL; Geiseler PJ; Nadler J; Richmond AS; Smith RP; Schiffman G; Shepard DS
    N Engl J Med; 1986 Nov; 315(21):1318-27. PubMed ID: 3534568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumococcal vaccine.
    LaForce FM
    Semin Respir Infect; 1989 Dec; 4(4):293-8. PubMed ID: 2697052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection.
    Klugman KP; Madhi SA; Huebner RE; Kohberger R; Mbelle N; Pierce N;
    N Engl J Med; 2003 Oct; 349(14):1341-8. PubMed ID: 14523142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG antibody concentrations after immunization with 11-valent mixed-carrier pneumococcal conjugate vaccine in efficacy trial against pneumonia among Filipino infants.
    Soininen A; Nohynek H; Lucero M; Jousimies K; Ugpo J; Williams G; Käyhty H;
    Vaccine; 2009 May; 27(20):2680-8. PubMed ID: 19428879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine.
    Millar EV; O'Brien KL; Bronsdon MA; Madore D; Hackell JG; Reid R; Santosham M
    Clin Infect Dis; 2007 May; 44(9):1173-9. PubMed ID: 17407035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serotype 5 pneumococcus in epidemiology and vaccine].
    Lafaix C; Meignan S; Biron G; Armand J
    Bull Eur Physiopathol Respir; 1983; 19(2):195-7. PubMed ID: 6871497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.
    Shapiro ED; Berg AT; Austrian R; Schroeder D; Parcells V; Margolis A; Adair RK; Clemens JD
    N Engl J Med; 1991 Nov; 325(21):1453-60. PubMed ID: 1944423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of pneumococcal vaccine in severe chronic obstructive pulmonary disease.
    Leech JA; Gervais A; Ruben FL
    CMAJ; 1987 Feb; 136(4):361-5. PubMed ID: 3545418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody response to pneumococcal vaccine in middle-aged and elderly patients recently treated for pneumonia.
    Hedlund JU; Kalin ME; Ortqvist AB; Henrichsen J
    Arch Intern Med; 1994 Sep; 154(17):1961-5. PubMed ID: 8074600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine.
    Broome CV; Facklam RR; Fraser DW
    N Engl J Med; 1980 Sep; 303(10):549-52. PubMed ID: 6995835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults.
    Hak E; Grobbee DE; Sanders EA; Verheij TJ; Bolkenbaas M; Huijts SM; Gruber WC; Tansey S; McDonough A; Thoma B; Patterson S; van Alphen AJ; Bonten MJ
    Neth J Med; 2008 Oct; 66(9):378-83. PubMed ID: 18990781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumococcal vaccines: World Health Organization position paper.
    Can Commun Dis Rep; 1999 Sep; 25(17):150-1. PubMed ID: 10513118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing pneumococcal bacteremia in patients at risk. Results of a matched case-control study.
    Farr BM; Johnston BL; Cobb DK; Fisch MJ; Germanson TP; Adal KA; Anglim AM
    Arch Intern Med; 1995 Nov; 155(21):2336-40. PubMed ID: 7487259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preimmunization and postimmunization pneumococcal antibody titers in children with recurrent infections.
    Hidalgo H; Moore C; Leiva LE; Sorensen RU
    Ann Allergy Asthma Immunol; 1996 Apr; 76(4):341-6. PubMed ID: 8612116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A reassessment of pneumococcal vaccine.
    Austrian R
    N Engl J Med; 1984 Mar; 310(10):651-3. PubMed ID: 6363925
    [No Abstract]   [Full Text] [Related]  

  • 16. Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies.
    Siber GR; Chang I; Baker S; Fernsten P; O'Brien KL; Santosham M; Klugman KP; Madhi SA; Paradiso P; Kohberger R
    Vaccine; 2007 May; 25(19):3816-26. PubMed ID: 17368878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological responses to pneumococcal vaccine in frail older people.
    Ridda I; Macintyre CR; Lindley R; Gao Z; Sullivan JS; Yuan FF; McIntyre PB
    Vaccine; 2009 Mar; 27(10):1628-36. PubMed ID: 19100304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revaccination of renal transplant and hemodialysis recipients with pneumococcal vaccine.
    Linnemann CC; First MR; Schiffman G
    Arch Intern Med; 1986 Aug; 146(8):1554-6. PubMed ID: 3524494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
    Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
    Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody response to pneumolysin and to pneumococcal capsular polysaccharide in healthy individuals and Streptococcus pneumoniae infected patients.
    Huo Z; Spencer O; Miles J; Johnson J; Holliman R; Sheldon J; Riches P
    Vaccine; 2004 Mar; 22(9-10):1157-61. PubMed ID: 15003643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.